Newbridge Capital

Newbridge Pharmaceuticals is a specialty pharmaceutical company headquartered in Dubai, United Arab Emirates, that focuses on the Middle East, Africa, Turkey, and Caspian (AfMET) regions. The company operates as a strategic partner for global biotechnology and pharmaceutical firms, providing a comprehensive platform for the in-licensing, registration, and commercialization of innovative therapeutics. Their portfolio is primarily centered on high-value therapeutic areas including oncology, immunology, neuroscience, and rare diseases. Newbridge addresses significant unmet medical needs in emerging markets by bridging the gap between Western drug developers and regional patient populations. The company's expertise spans regulatory affairs, market access, and specialized commercial execution.